clopidogrel has been researched along with Kidney Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 16 (55.17) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Della Pasqua, O; Duong, JK; Gross, AS; Nand, RA; Patel, A | 1 |
| Chen, J; Huang, XR; Lan, HY; Tang, PM; Tang, Y; Wei, B; Xu, A; Zhong, Y | 1 |
| Chang, WL; Chen, PL; Guo, YC; Hsu, CY; Lien, LM; Sun, Y; Sung, FC; Wang, IK; Yang, YC; Yen, TH | 1 |
| Metkus, TS | 1 |
| Baber, M; HamidAkash, MS; Hussain, SB; Irfan, M; Qadir, MI; Rehman, A | 1 |
| Bologna, F; Bordignon, S; Chen, S; Chun, KRJ; Konstantinou, A; Nagase, T; Perrotta, L; Schmidt, B; Weise, FK | 1 |
| Cai, L; Cheng, Y; Fu, Y; Gao, J; Gozal, E; Lian, X; Lu, X; Ma, T; Rane, MJ; Sun, W; Wang, W; Weng, W; Zheng, Z | 1 |
| Baber, U; Badimon, JJ; Bander, J; Gukathasan, N; Hadi, A; Karajgikar, R; Kini, AS; Kovacic, JC; Mehran, R; Moreno, P; Muntner, P; Roy, S; Sartori, S; Sayeneni, S; Scott, SA; Sharma, SK; Theodoropolous, K; Uribarri, J; Yadav, K; Yu, J | 1 |
| Cuschieri, JR; Drawz, P; Falck-Ytter, Y; Wong, RC | 1 |
| Halicioglu, S; Kargı, E; Ozyalvacli, ME; Uyeturk, U | 1 |
| Choi, SY; Guo, LZ; Jin, E; Kim, MH; Kim, TH; Park, JS; Serebruany, VL; Shim, CH | 1 |
| Artesiani, ML; Bazzoli, F; Eusebi, LH; Gelli, D; Montagnani, M; Rabitti, S; Zagari, RM | 1 |
| Alberts, P; Bounameaux, H; Fontana, P; Mann, J; Sakariassen, KS; Sorensen, AS | 1 |
| Istad, R; Ringdal, MA; Tangen, G; Tølløfsrud, S; Øvrum, E; Øystese, R | 1 |
| Aylward, P; Buck, KK; Budaj, A; Cannon, CP; Cornel, JH; Harrington, RA; Horrow, J; James, S; Katus, H; Keltai, M; Lewis, BS; Parikh, K; Storey, RF; Szummer, K; Wallentin, L; Wojdyla, D | 1 |
| Cho, HJ; Jeon, KH; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Oh, IY; Park, JJ; Park, KW; Park, YB; Yang, HM | 1 |
| Banya, W; Bigalke, B; Bischofs, C; Fateh-Moghadam, S; Flather, M; Gawaz, M; Geisler, T; Htun, P; May, AE; Müller, K; Stellos, K | 1 |
| Basra, SS; Lakkis, NM; Tsai, P | 1 |
| Jung, KH; Kim, W; Kim, WS; Lee, SR; Lee, TW; Lew, JH; Lim, CK; Woo, JS | 1 |
| Bae, EH; Choi, JS; Choi, YH; Jeong, MH; Kim, CS; Kim, SW; Lim, SY; Ma, SK; Sim, DS; Suh, SH | 1 |
| DiNicolantonio, JJ; Serebruany, VL | 1 |
| Fernandez, JS; Sadaniantz, A; Sadaniantz, BT | 1 |
| Agil, C; Akay, F; Akay, H; Bahceci, M; Tuzcu, A | 1 |
| Otrock, ZK; Sawaya, JI; Taher, AT; Zebian, RC | 1 |
| Bhandari, S; Clark, AL; Cleland, JG; de Silva, R; Loh, H; Nicholson, A; Nikitin, NP; Rigby, AS; Witte, KK | 1 |
| Berry, C; Bonan, R; Dorval, JF; Soulez, G | 1 |
| Chen, X; Chen, Y; Li, J; Shi, S; Tu, X; Wang, J; Xie, Y | 1 |
| McCarthy, C; Roberti, I; Vyas, S | 1 |
4 review(s) available for clopidogrel and Kidney Diseases
| Article | Year |
|---|---|
Proton pump inhibitors: Risks of long-term use.
Topics: Calcium; Cardiovascular Diseases; Clopidogrel; Dementia; Drug Interactions; Fractures, Bone; Gastrointestinal Neoplasms; Humans; Intestinal Absorption; Kidney Diseases; Pneumonia; Proton Pump Inhibitors; Risk; Ticlopidine; Time Factors; Vitamins | 2017 |
Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Humans; Kidney Diseases; Platelet Aggregation Inhibitors; Proteinuria; Receptors, Thrombin; Thrombosis; Thromboxane A2; Thromboxane-A Synthase; Ticlopidine | 2009 |
Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease.
Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Chronic Disease; Clinical Trials as Topic; Clopidogrel; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Hemorrhage; Heparin; Hirudins; Humans; Kidney Diseases; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Recombinant Proteins; Thiophenes; Ticagrelor; Ticlopidine; Uremia | 2011 |
Review of antithrombotic agents used for acute coronary syndromes in renal patients.
Topics: Acute Disease; Anticoagulants; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhagic Disorders; Humans; Kidney Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Ticlopidine | 2003 |
4 trial(s) available for clopidogrel and Kidney Diseases
| Article | Year |
|---|---|
Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Aprotinin; Blood Transfusion; Cerebrovascular Disorders; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Female; Hemostatics; Humans; Intraoperative Care; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Postoperative Hemorrhage; Prospective Studies; Ticlopidine; Time Factors; Treatment Outcome | 2010 |
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Cardiovascular Diseases; Chronic Disease; Clopidogrel; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Ticagrelor; Ticlopidine; Treatment Outcome | 2010 |
Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney di
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cilostazol; Clopidogrel; Coronary Artery Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Renal Dialysis; Tetrazoles; Ticlopidine | 2011 |
Triple vs. dual antiplatelet therapy in patients with acute myocardial infarction and renal dysfunction.
Topics: Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Survival Rate; Tetrazoles; Ticlopidine | 2012 |
21 other study(ies) available for clopidogrel and Kidney Diseases
| Article | Year |
|---|---|
A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity.
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Female; Fluvoxamine; Glucuronides; Humans; Japan; Kidney Diseases; Male | 2022 |
P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.
Topics: Animals; Clopidogrel; Fibrosis; Kidney; Kidney Diseases; Macrophages; Mice; Mice, Inbred C57BL; Myofibroblasts; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ureteral Obstruction | 2022 |
Antiplatelet agents for the secondary prevention of ischaemic stroke in patients with or without renal dysfunction.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Incidence; Ischemic Stroke; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Renal Dialysis; Risk Assessment; Secondary Prevention; Taiwan | 2020 |
Searching for the Ideal Antiplatelet Therapy for CABG Patients With Kidney Disease.
Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Humans; Kidney Diseases; Platelet Aggregation Inhibitors | 2022 |
Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Biomarkers; Blood Urea Nitrogen; Clopidogrel; Creatinine; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome; Uric Acid | 2016 |
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Transesophageal; Feasibility Studies; Female; Germany; Hemorrhage; Humans; Incidence; Kidney; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2018 |
Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis.
Topics: Animals; Blood Coagulation; Blotting, Western; Clopidogrel; Diabetes Mellitus, Experimental; Fibronectins; Fibrosis; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Purinergic P2Y Receptor Antagonists | 2019 |
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity.
Topics: Aged; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Function Tests; Preoperative Care; Prospective Studies; Receptors, Purinergic P2Y12; Risk; Thrombosis; Ticlopidine; Treatment Outcome | 2013 |
Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.
Topics: Acute Disease; Age Factors; Aged; Anticoagulants; Chronic Disease; Clopidogrel; Female; Gastrointestinal Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Ohio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Veterans; Warfarin | 2014 |
Spontaneous renal parenchymal hematoma associated with clopidogrel in a patient with diabetic nephropathy.
Topics: Aged; Clopidogrel; Diabetic Nephropathies; Hematoma; Humans; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Renal Dialysis; Retroperitoneal Space; Ticlopidine | 2015 |
Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy.
Topics: Aged; Aspirin; Clopidogrel; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombosis; Ticlopidine | 2016 |
Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans.
Topics: Age Factors; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Asian People; Biomarkers; Blood Platelets; C-Reactive Protein; Chi-Square Distribution; Chronic Disease; Clopidogrel; Diabetes Mellitus; Female; Humans; Kidney Diseases; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Republic of Korea; Risk Assessment; Risk Factors; Sex Factors; Smoking; Stents; Ticlopidine; Treatment Outcome | 2012 |
Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chronic Disease; Clopidogrel; Cohort Studies; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome | 2011 |
Angiotensin receptor blockers worsen renal function and dyspnea on ticagrelor: a potential ticagrelor-angiotensin receptor blocker interaction?
Topics: Adenosine; Angiotensin II Type 1 Receptor Blockers; Clopidogrel; Drug Interactions; Dyspnea; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Ticagrelor; Ticlopidine; United States; United States Food and Drug Administration | 2012 |
Serious clopidogrel associated renal hematoma in a type 2 diabetic patient with primary hyperparathyroidism after extracorporeal shock wave lithotripsy.
Topics: Clopidogrel; Diabetes Mellitus, Type 2; Hematoma; Humans; Hyperparathyroidism, Primary; Kidney Calculi; Kidney Diseases; Lithotripsy; Male; Middle Aged; Nephrectomy; Platelet Aggregation Inhibitors; Ticlopidine | 2005 |
Spontaneous abdominal hematoma in a patient treated with clopidogrel and aspirin.
Topics: Abdominal Cavity; Abdominal Pain; Aged; Aspirin; Clopidogrel; Hematoma; Humans; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.
Topics: Aged; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Clopidogrel; Creatinine; Female; Heart Failure; Humans; Kidney Diseases; Magnetic Resonance Angiography; Male; Prognosis; Prospective Studies; Renal Artery Obstruction; Risk Factors; Severity of Illness Index; Sickness Impact Profile; Ticlopidine; Treatment Outcome | 2007 |
Management of a spontaneous renal capsule hematoma following cardiac catheterization involving use of a platelet glycoprotein IIb/IIIa inhibitor: a case report.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Catheterization; Clopidogrel; Coronary Stenosis; Embolization, Therapeutic; Female; Hematoma; Humans; Immunoglobulin Fab Fragments; Kidney Diseases; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radiography, Interventional; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Chronic Disease; Clopidogrel; Creatinine; Hypertension; Irbesartan; Kidney; Kidney Diseases; Nephrectomy; Platelet Aggregation Inhibitors; Rats; Tetrazoles; Ticlopidine; Wounds and Injuries | 2008 |
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Topics: Acute Coronary Syndrome; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Chronic Disease; Clopidogrel; Contraindications; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Coronary Stenosis; Drug-Eluting Stents; Electrocardiography; Evidence-Based Medicine; Exercise Test; Humans; Kidney Diseases; Myocardial Infarction; Nomograms; Patient Selection; Platelet Aggregation Inhibitors; Prognosis; Radionuclide Ventriculography; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Stents; Stroke Volume; Thrombolytic Therapy; Ticlopidine | 2008 |
May-Thurner syndrome in a pediatric renal transplant recipient--case report and literature review.
Topics: Adolescent; Clopidogrel; Creatinine; Edema; Female; Graft Survival; Humans; Iliac Vein; Kidney Diseases; Kidney Transplantation; Lymphocele; Stockings, Compression; Syndrome; Ticlopidine; Treatment Outcome; Vascular Diseases | 2008 |